Informed Consent Form Formulář Sample Clauses

Informed Consent Form Formulář informovaného souhlasu The form prepared by CRO/Sponsor in conformance with the Regulations (as hereinafter defined), particularly by Decree No. 226/2008 Coll. on the Good Clinical Practice and Detailed Conditions for Clinical Studies of Pharmaceuticals, as amended, in consultation with Sponsor, CRO, and the IEC/ SÚKL (as hereinafter defined), approved by the IEC/ SÚKL and signed and dated by all participants or their legal representative(s) before they begin to participate in the Study. Formulář připravený společností CRO a/nebo Zadavatelem v souladu s vyhláškou č. 226/2008 Sb., kterou se stanovuje správná klinická praxe a bližší podmínky klinického hodnocení léčiv, ve znění pozdějších předpisů, a dalšími platnými Právními předpisy (které jsou definovány níže) na základě konzultace se Zadavatelem, společností CRO a NEK/SÚKL (které jsou definovány níže), který byl schválen NEK/SÚKL a byl podepsán všemi účastníky nebo jejich právním zástupcem(ci) před zahájením jejich účasti v Klinickém hodnocení.
Sample 1Sample 2See All (5)
AutoNDA by SimpleDocs
Informed Consent Form Formulář informovaného souhlasu The form prepared by ICON/the Sponsor in conformance with the Regulations (as hereinafter defined), in consultation with the Sponsor, ICON, and the IRB/IEC (as hereinafter defined), approved by the IRB/IEC and signed by all participants before they begin to participate in the Study. Formulář připravený společností ICON / zadavatelem v souladu se zákonnými předpisy (jak je definováno níže) ve spolupráci se zadavatelem, společností ICON a IRB/IEC (jak je definováno níže), schválený ze strany IRB/IEC a podepsaný všemi účastníky před zahájením jejich účasti ve studii.
Sample 1Sample 2
Informed Consent Form Formulář informovaného souhlasu The form prepared by ICON/the Sponsor in conformance with the Regulations (as hereinafter defined), in consultation with the Sponsor, ICON, and the IEC (as hereinafter defined), approved by the EC and signed by all participants before they begin to participate in the Study. Formulář připravený společností ICON / zadavatelem v souladu se zákonnými předpisy (jak je definováno níže) ve spolupráci se zadavatelem, společností ICON a IEC (jak je definováno níže), schválený ze strany EC a podepsaný všemi účastníky před zahájením jejich účasti ve studii.
Sample 1
Informed Consent Form Formulář informovaného souhlasu The form prepared by ICON/the Sponsor in conformance with the Regulations (as hereinafter defined), particularly by Decree No. 226/2008 Coll. on the Good Clinical Practice and Detailed Conditions for Clinical Studies of Pharmaceuticals, as amended, in consultation with the Sponsor, ICON, and the IEC/ SÚKL (as hereinafter defined), approved by the IEC/ SÚKL and signed and dated by all participants or their legal representative(s) before they begin to participate in the Study. Formulář připravený společností ICON/Zadavatelem v souladu s vyhláškou č. 226/2008 Sb., kterou se stanovuje správná klinická praxe a bližší podmínky klinického hodnocení léčiv, ve znění pozdějších předpisů, a dalšími platnými Právními předpisy (které jsou definovány níže) na základě konzultace se Zadavatelem, společností ICON a NEK/SÚKL (které jsou definovány níže), který byl schválen NEK/SÚKL a byl podepsán všemi subjekty nebo jejich právním zástupcem(ci) před zahájením jejich účasti v Klinickém hodnocení. 2.5 Investigational Product Hodnocené léčivo The Investigational Product(s) which is/are the subject matter of the Protocol. Hodnocené/á léčivo/a, které/á je/jsou předmětem Protokolu 2.6 IEC (Independent Ethics Committee) NEK (Nezávislá etická komise) The board, committee or other group formally instituted to review and approve the initiation of, and conduct reviews of, biomedical research involving human subjects. Výbor, komise nebo jiná skupina formálně vytvořená za účelem kontroly, schválení zahájení a provádění kontroly biomedicínckých výzkumů zahrnujících lidské subjekty. SÚKL SÚKL State Institute for Control of Drugs Státní ústav pro kontrolu léčiv
Sample 1

Related to Informed Consent Form Formulář

  • Interest Questionnaire - Form CIQ No response Do not upload this form unless you have a reportable conflict with TIPS. There is an Attribute entitled “Conflict of Interest Questionnaire Requirement” immediately followed by an Attribute entitled “Conflict of Interest Questionnaire Requirement – Form CIQ – Continued.” Properly respond to those Attributes and only upload this form if applicable/instructed. If upload is required based on your response to those Attributes, the Conflict of Interest Questionnaire – Form CIQ must be downloaded from the “Attachments” section of the IonWave eBid System, reviewed, properly completed, and uploaded at this location. Vendor’s Warranties, Terms, and Conditions (Supplemental Vendor Information Only)

  • EFFECTIVE DATE AND NOTICE OF NONLIABILITY This Agreement shall not be effective or enforceable until it is approved and signed by the State Controller or its designee (hereinafter called the “Effective Date”), but shall be effective and enforceable thereafter in accordance with its provisions. The State shall not be liable to pay or reimburse Contractor for any performance hereunder or be bound by any provision hereof prior to the Effective Date.

  • Certificate of Interested Parties Form – Form 1295 As required by Section 2252.908 of the Texas Government Code. H-GAC will not enter a Contract with Contractor unless (i) the Contractor submits a disclosure of interested parties form to H-GAC at the time the Contractor submits the contract H-GAC, or

  • MOTION FOR FINAL APPROVAL Not later than 16 court days before the calendared Final Approval Hearing, Plaintiff will file in Court, a motion for final approval of the Settlement that includes a request for approval of the PAGA settlement under Labor Code section 2699, subd. (l), a Proposed Final Approval Order and a proposed Judgment (collectively “Motion for Final Approval”). Plaintiff shall provide drafts of these documents to Defense Counsel not later than seven days prior to filing the Motion for Final Approval. Class Counsel and Defense Counsel will expeditiously meet and confer in person or by telephone, and in good faith, to resolve any disagreements concerning the Motion for Final Approval.

  • Disclosure Statement for Xxxx IRAs 1. Am I Eligible to Contribute to a Xxxx XXX? Anyone with compensation income whose Modified Adjusted Gross Income (AGI) does not exceed the limits described below is eligible to contribute to a Xxxx XXX. (For convenience, all future references to compensation are deemed to mean “earned income” in the case of a self- employed individual.) Employers may also contribute to Xxxx IRAs established for the benefit of their employees. You may also establish a Xxxx XXX to receive rollover contributions or transfers from another Xxxx XXX or, in some cases, from a Traditional IRA. A Qualified Rollover Contribution can be made to a Xxxx XXX and is a distribution from an IRA that meets the requirements of section 408(d)(3), a rollover from a designated Xxxx account described in section 402A, or a rollover from an eligible retirement plan as described in section 402(c)(8)(B).

  • Conflict of Interest Questionnaire - Form CIQ No response Do not upload this form unless you have a reportable conflict with TIPS. There is an Attribute entitled “Conflict of Interest Questionnaire Requirement” immediately followed by an Attribute entitled “Conflict of Interest Questionnaire Requirement – Form CIQ – Continued.” Properly respond to those Attributes and only upload this form if applicable/instructed. If upload is required based on your response to those Attributes, the Conflict of Interest Questionnaire – Form CIQ must be downloaded from the “Attachments” section of the IonWave eBid System, reviewed, properly completed, and uploaded at this location. Vendor’s Warranties, Terms, and Conditions (Supplemental Vendor Information Only)

  • Renewal Notice; Notification of Changes Subject to governing law, XOOM can renew this Agreement with new or revised Terms. XOOM will send you written notice at least (30) days before the end of the Term. The notice will specify the date by which you must advise XOOM if you do not want to renew your Agreement. If you do not advise XOOM by the specified date, this Agreement will automatically renew at the fixed rate or variable rate then in effect in accordance with the notice. XOOM reserves the right, with fifteen (15) days’ notice, to amend this Agreement to adjust its service to accommodate any change in regulations, law, tariff or other change in procedure required by any third party that may affect XOOM’s ability to continue to serve you under this Agreement.

  • Conflict of Interest Questionnaire Requirement - Form CIQ - Continued If you responded "No, Vendor does not certify - VENDOR HAS CONFLICT" to the Conflict of Interest Questionnaire question above, you are required by law to fully execute and upload the form attachment entitled "Conflict of Interest Questionnaire - Form CIQ." If you accurately claimed no conflict above, you may disregard the form attachment entitled "Conflict of Interest Questionnaire - Form CIQ." Have you uploaded this form if applicable? Not Applicable

  • Final Meeting Benefits Questionnaire Provide all key assumptions used to estimate projected benefits, including targeted market sector (e.g., population and geographic location), projected market penetration, baseline and projected energy use and cost, operating conditions, and emission reduction calculations. Examples of information that may be requested in the questionnaires include:

  • New Application for Licensure Any time after the three-month period has lapsed from the Effective Date of this Agreement and Respondent has paid the Administrative Penalty set forth in Section III, Paragraph 1 of this Order, Respondent may apply for a new mortgage loan originator license or, as applicable, petition for the reinstatement of an MLO Activity Endorsement in any or all of the Participating States with the understanding that each State Mortgage Regulator reserves the rights to fully investigate such application for licensure or petition for reinstatement of an MLO Activity Endorsement and may either approve or deny such application or petition pursuant to the normal process for such licensing or endorsement investigations. No license application or petition described in this paragraph will be denied solely based on the facts, circumstances, or consensual resolution provided for in this Agreement. Respondent further agrees that Respondent must satisfy the Administrative Penalty provision prior to submitting an application for a new mortgage loan originator license or, as applicable, petition for the reinstatement of an MLO Activity Endorsement.

Time is Money Join Law Insider Premium to draft better contracts faster.